These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 31662348)

  • 1. Use of cerebrospinal fluid CXCL10 and neopterin as biomarkers in HTLV-1-associated myelopathy/tropical spastic paraparesis treated with steroids.
    Yamauchi J; Sato T; Yagishita N; Araya N; Hasegawa D; Tsutsumi S; Nagasaka M; Coler-Reilly A; Inoue E; Takata A; Hasegawa Y; Yamano Y
    J Neurol Neurosurg Psychiatry; 2020 Mar; 91(3):321-323. PubMed ID: 31662348
    [No Abstract]   [Full Text] [Related]  

  • 2. Multicenter, randomized, double-blind, placebo-controlled phase 3 study of mogamulizumab with open-label extension study in a minimum number of patients with human T-cell leukemia virus type-1-associated myelopathy.
    Sato T; Nagai M; Watanabe O; Misu T; Takenouchi N; Ohkubo R; Ishihara S; Tsuboi Y; Katsuno M; Nakagawa M; Matsushita T; Aso Y; Matsuura E; Tokashiki T; Mukaino A; Adachi H; Nakanishi K; Yamaguchi Y; Yamaguchi S; Yamano Y
    J Neurol; 2024 Jun; 271(6):3471-3485. PubMed ID: 38430272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CSF CXCL10, CXCL9, and neopterin as candidate prognostic biomarkers for HTLV-1-associated myelopathy/tropical spastic paraparesis.
    Sato T; Coler-Reilly A; Utsunomiya A; Araya N; Yagishita N; Ando H; Yamauchi J; Inoue E; Ueno T; Hasegawa Y; Nishioka K; Nakajima T; Jacobson S; Izumo S; Yamano Y
    PLoS Negl Trop Dis; 2013; 7(10):e2479. PubMed ID: 24130912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and laboratory features of HTLV-I asymptomatic carriers and patients with HTLV-I-associated myelopathy/tropical spastic paraparesis from the Brazilian Amazon.
    Takatani M; Crispim ME; Fraiji N; Stefani MM; Kiesslich D
    Rev Inst Med Trop Sao Paulo; 2017 Apr; 59():e5. PubMed ID: 28380116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human T lymphotropic virus type I (HTLV-I) proviral load in cerebrospinal fluid: a new criterion for the diagnosis of HTLV-I-associated myelopathy/tropical spastic paraparesis?
    Lezin A; Olindo S; Oliere S; Varrin-Doyer M; Marlin R; Cabre P; Smadja D; Cesaire R
    J Infect Dis; 2005 Jun; 191(11):1830-4. PubMed ID: 15871115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid neopterin, but not osteopontin, is a valuable biomarker for the treatment response in patients with HTLV-I-associated myelopathy.
    Nagai M; Tsujii T; Iwaki H; Nishikawa N; Nomoto M
    Intern Med; 2013; 52(19):2203-8. PubMed ID: 24088752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased HTLV-I proviral load and preferential expansion of HTLV-I Tax-specific CD8+ T cells in cerebrospinal fluid from patients with HAM/TSP.
    Nagai M; Yamano Y; Brennan MB; Mora CA; Jacobson S
    Ann Neurol; 2001 Dec; 50(6):807-12. PubMed ID: 11761481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue inhibitor of metalloproteinase 3, matrix metalloproteinase 9, and neopterin in the cerebrospinal fluid: preferential presence in HTLV type I-infected neurologic patients versus healthy virus carriers.
    Lezin A; Buart S; Smadja D; Akaoka H; Bourdonné O; Perret-Liaudet A; Césaire R; Belin MF; Giraudon P
    AIDS Res Hum Retroviruses; 2000 Jul; 16(10):965-72. PubMed ID: 10890358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of Daily Prednisolone to Slow Progression of Human T-Lymphotropic Virus Type 1-Associated Myelopathy/Tropical Spastic Paraparesis: A Multicenter Retrospective Cohort Study.
    Coler-Reilly ALG; Sato T; Matsuzaki T; Nakagawa M; Niino M; Nagai M; Nakamura T; Takenouchi N; Araya N; Yagishita N; Inoue E; Yamano Y
    Neurotherapeutics; 2017 Oct; 14(4):1084-1094. PubMed ID: 28536850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HTLV-I-associated myelopathy: analysis of 213 patients based on clinical features and laboratory findings.
    Nakagawa M; Izumo S; Ijichi S; Kubota H; Arimura K; Kawabata M; Osame M
    J Neurovirol; 1995 Mar; 1(1):50-61. PubMed ID: 9222342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neopterin in cerebrospinal fluid: a useful marker for diagnosis of HTLV-I-associated myelopathy/tropical spastic paraparesis.
    Nomoto M; Utatsu Y; Soejima Y; Osame M
    Neurology; 1991 Mar; 41(3):457. PubMed ID: 2006023
    [No Abstract]   [Full Text] [Related]  

  • 12. Levels of serum chemokines discriminate clinical myelopathy associated with human T lymphotropic virus type 1 (HTLV-1)/tropical spastic paraparesis (HAM/TSP) disease from HTLV-1 carrier state.
    Guerreiro JB; Santos SB; Morgan DJ; Porto AF; Muniz AL; Ho JL; Teixeira AL; Teixeira MM; Carvalho EM
    Clin Exp Immunol; 2006 Aug; 145(2):296-301. PubMed ID: 16879249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human T-lymphotropic virus type-I (HTLV-I)-associated myelopathy with bulbar palsy-type amyotrophic lateral sclerosis-like symptoms.
    Ando R; Nishikawa N; Tsujii T; Iwaki H; Yabe H; Nagai M; Nomoto M
    Intern Med; 2015; 54(9):1105-7. PubMed ID: 25948358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of human T-lymphotropic virus type I p40tax protein in cerebrospinal fluid cells from patients with human T-lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis.
    Moritoyo T; Izumo S; Moritoyo H; Tanaka Y; Kiyomatsu Y; Nagai M; Usuku K; Sorimachi M; Osame M
    J Neurovirol; 1999 Jun; 5(3):241-8. PubMed ID: 10414514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential patterns of serum biomarkers of immune activation in human T-cell lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis, and adult T-cell leukemia/lymphoma.
    Giusti RM; Maloney EM; Hanchard B; Morgan OS; Steinberg SM; Wachter H; Williams E; Cranston B; Fuchs D; Manns A
    Cancer Epidemiol Biomarkers Prev; 1996 Sep; 5(9):699-704. PubMed ID: 8877061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HTLV-I-associated myelopathy (HAM)/tropical spastic paraparesis (TSP) with amyotrophic lateral sclerosis-like manifestations.
    Matsuzaki T; Nakagawa M; Nagai M; Nobuhara Y; Usuku K; Higuchi I; Takahashi K; Moritoyo T; Arimura K; Izumo S; Akiba S; Osame M
    J Neurovirol; 2000 Dec; 6(6):544-8. PubMed ID: 11175327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Case report of HTLV-1 associated myelopathy (HAM) manifested after renal transplantation].
    Inose Y; Akiyama S; Mochizuki A; Shimizu Y; Iwata M; Uchiyama S
    Rinsho Shinkeigaku; 2010 Apr; 50(4):241-5. PubMed ID: 20411806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnosis and treatment of HTLV-I associated myelopathy].
    Osame M
    Nihon Naika Gakkai Zasshi; 1990 Mar; 79(3):261-5. PubMed ID: 2332679
    [No Abstract]   [Full Text] [Related]  

  • 19. Prosultiamine for treatment of lower urinary tract dysfunction accompanied by human T-lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis.
    Matsuo T; Miyata Y; Nakamura T; Satoh K; Sakai H
    Int J Urol; 2018 Jan; 25(1):54-60. PubMed ID: 28965354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of HTLV-1 virulence factors (HBZ, Tax, proviral load), HLA class I and plasma neopterin on manifestation of HTLV-1 associated myelopathy tropical spastic paraparesis.
    Tarokhian H; Taghadosi M; Rafatpanah H; Rajaei T; Azarpazhooh MR; Valizadeh N; Rezaee SAR
    Virus Res; 2017 Jan; 228():1-6. PubMed ID: 27845163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.